Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 12 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Anixa Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 12 filings
- 2 insiders, $321.1K in total
- Open-market sells
- 0 filings
- Insiders trading
- 2
- Net value
- +$321.1K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Anixa Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Titterton Lewis H jr | Director | 1,046,003 | Sep 25, 2026 | 7 |
| Kumar Amit | Chief Executive Officer | 665,000 | Sep 14, 2026 | 11 |
| Baskies Arnold M | Director | 135,572 | Jul 29, 2026 | 3 |
| Catelani Michael | President, COO & CFO | 44,500 | Jan 6, 2026 | 1 |
| Gottschalk Emily | Director | 45,665 | Jan 6, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)6:19 PM ET | Jul 20 | Same day | Titterton Lewis H jrDirector | PPurchase | +12.0K | $3.47 | +$41.6K | +1.2%987.0K after | |
| Jul 21, 2026 (view filing)10:23 AM ET | Jul 20 | 1 day | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $3.46 | +$17.3K | +0.8%640.8K after | |
| Jul 27, 2026 (view filing)9:00 AM ET | Jul 24 | 3 days | Kumar AmitChief Executive Officer | PPurchase | +3.00K | $3.73 | +$11.2K | +0.5%643.8K after | |
| Jul 27, 2026 (view filing)3:25 PM ET | Jul 27 | Same day | Kumar AmitChief Executive Officer | PPurchase | +3.19K | $3.37 | +$10.7K | +0.5%647.0K after | |
| Jul 28, 2026 (view filing)10:20 AM ET | Jul 27 | 1 day | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $3.44 | +$17.2K | +0.8%652.0K after | |
| Aug 3, 2026 (view filing)8:45 AM ET | Jul 31 | 3 days | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $3.47 | +$17.4K | +0.8%657.0K after | |
| Sep 11, 2026 (view filing)8:00 AM ET | Sep 10 | 1 day | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $2.76 | +$13.8K | +0.8%662.0K after | |
| Sep 14, 2026 (view filing)9:15 AM ET | Sep 10 | 4 days | Titterton Lewis H jrDirector | PPurchase | +10.0K | $2.73 | +$27.3K | +1.0%997.0K after | |
| Sep 14, 2026 (view filing)9:45 AM ET | Sep 10 | 4 days | Kumar AmitChief Executive Officer | PPurchase | +3.00K | $2.75 | +$8.25K | +0.5%665.0K after | |
| Sep 25, 2026 (view filing)8:39 AM ET | Sep 23 | 2 days | Titterton Lewis H jrDirector | PPurchase | +49.0K | $2.69 | +$131.9K | +4.9%1.05M after |